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Abstract
Introduction: Several studies reported the negative impact of elevated neutrophil/lymphocyte ratio (NLR) on outcomes in
many surgical and medical conditions. Previous studies used arbitrary NLR cut-off points according to the average of the
populations under study. There is no data on the average NLR in the general population. The aim of this study is to explore
the average values of NLR and according to race in adult non-institutional United States individuals by using national data.
Methods: The National Health and Nutrition Examination Survey (NHANES) of aggregated cross-sectional data collected
from 2007 to 2010 was analyzed; data extracted included markers of systemic inflammation (neutrophil count, lymphocyte
count, and NLR), demographic variables and other comorbidities. Subjects who were prescribed steroids, chemotherapy,
immunomodulators and antibiotics were excluded. Adjusted linear regression models were used to examine the association
between demographic and clinical characteristics and neutrophil counts, lymphocyte counts, and NLR.
Results: Overall 9427 subjects are included in this study. The average value of neutrophils is 4.3k cells/mL, of lymphocytes
2.1k cells/mL; the average NLR is 2.15. Non-Hispanic Black and Hispanic participants have significantly lower mean NLR
values (1.76, 95% CI 1.71–1.81 and 2.08, 95% CI 2.04–2.12 respectively) when compared to non-Hispanic Whites (2.24, 95%
CI 2.19–2.28–p,0.0001). Subjects who reported diabetes, cardiovascular disease, and smoking had significantly higher NLR
than subjects who did not. Racial differences regarding the association of smoking and BMI with NLR were observed.
Conclusions: This study is providing preliminary data on racial disparities in a marker of inflammation, NLR, that has been
associated with several chronic diseases outcome, suggesting that different cut-off points should be set according to race. It
also suggests that racial differences exist in the inflammatory response to environmental and behavioral risk factors.
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These studies corroborate the negative impact of elevated NLR,
however they differ in their NLR cutoff points. While some studies
categorized their patients according to NLR intervals (e.g. tertiles,
quartiles, quintiles) [11–13], other studies used definite NLR cutoff
points (e.g. NLR$2.5 [14], NLR$2.7 [15], NLR$3 [16], NLR$
4 [17], and others used NLR$5 [18–20]. Of note, the studies from
western countries often used higher NLR cutoff points compared
to other ethnicity (e.g. Asian and African), which reflect well
known racial difference in the normal range of neutrophil and
lymphocyte counts [21,22]. It is not known, however, if differences
observed in NLR reflect real variation among healthy human
subjects, or are related to the lack of standardization in the
measurement of this biomarker. In fact, studies report differ timing
for the collection of blood used to calculate NLR; some collect the

Introduction
Inflammation plays a major role in the pathophysiology of
commonly considered non-inflammatory diseases, such as cancer
and atherosclerosis [1–4]. Among many inflammatory markers,
several studies demonstrated that elevated neutrophil/lymphocyte
ratio (NLR) is a significant predictor of adverse outcomes for
patients with cardiovascular disease or cancer [5–8]. NLR is
believed to reflect the balance between innate (neutrophils) and
adaptive (lymphocytes) immune responses. Previous research has
shown that elevated NLR is associated with increased concentration of various pro-inflammatory cytokines [8–10] which may
cause cellular DNA damage.
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Table 1. Sample characteristics among NHANES 2007–2010 participants (n = 9427).

Subjects
tested (N)

Weighted
Prevalence
(95% CI)

Variable

Categories

Race

Hispanic

2904

14.72 (10.92–18.53)

Non-Hispanic White

4270

67.11 (61.77–72.44)

Non-Hispanic Black

1756

11.03 8.92–13.14)

Other Non-Hispanic

497

07.14 (5.46–8.82)

Male

4625

49.03 (47.95–50.11)

Female

4802

50.97 (49.89–52.04)

9427

47.56 (46.92–48.21)

, high school

2842

19.96 (18.15–21.77)

Sex

Age (years)
Education

High school or equiv

2246

24.09 (22.31–25.88)

. high school

4325

55.84 (53.12–58.57)

8548

2.97 (2.88–3.07)

Health insurance

Insured

6871

78.33 (76.56–80.10)

Diabetes

Yes

1044

7.64 (6.69–8.60)

Borderline

162

1.6 (1.25–1.86)

Yes

517

4.06 (3.57–4.55)

Income/poverty ratio

Heart condition
2

BMI (kg/m )

,18.5

140

1.64 (1.20–2.10)

18.5–24.9

2469

29.20 (27.60–30.79)

25.0–29.9

3167

33.82 (32.37–35.27)

$30.0

3562

35.34 (33.78–36.90)

Ever Smoker

Yes

4322

44.85 (42.37–47.34)

Current Drinker

Yes

6213

76.64 (74.43–78.55)

Segmented
Neutrophils
(1000 cells/mL)

9427

4.27 (4.20–4.34)

Lymphocytes
(1000 cells/mL)

9427

2.14 (2.11–2.16)

Neutrophil/lymphocyte
ratio (NLR)

9427

2.15 (2.11–2.19)

Mean (95% CI)

doi:10.1371/journal.pone.0112361.t001

(age, sex, race, Body Mass Index) and clinical (history of diabetes,
heart disease or heart attack) characteristics.
In the 2007–2008 NHANES survey, there were 8249 subjects of
both sexes, aged $18 years, who had complete data on neutrophil
or lymphocyte counts; 3,427 participants were excluded for
reporting a history of cancer or malignancy or missing data on
cancer or malignancy. An additional 279 participants were
excluded for self- report of taking any of the following medications:
steroids, chemotherapy, immunomodulators, antibiotics, leaving
4,548 subjects (55% of the original sample). In the 2009–2010
survey, the same exclusion criteria were applied; from the initial
8,786 men and women who had neutrophil and lymphocyte data,
a total of 4,884 participants (approximately 56% of the original
sample) were included in the present analysis. The final sample
consisted of 9,427 subjects across both survey waves.

blood sample on admission [23], others use preoperative NLR
[24], maximum NLR during hospitalization [13], or average NLR
of three readings during hospitalization [25]. Nevertheless, there is
no study to our knowledge exploring the normal range and
variability of NLR in a healthy population. Aim of this study was
to investigate the normal range of NLR and its relationship with
other demographic, risk factor and comorbidity variables in a wellknown maintained national database of non-institutional individuals (NHANES).

Methods
Study design and participants
The National Health and Nutrition Examination Survey
(NHANES) is a population-based survey designed to assess the
health and nutritional status of non-institutionalized children and
adults in the United States. NHANES uses a complex, multistage,
probability sampling design to produce a nationally representative
sample of non-institutionalized US children and adults. In this
study, we aggregated cross-sectional data collected from 2007 to
2010; data extracted included markers of systemic inflammation
(neutrophil count, lymphocyte count, and NLR), demographic

PLOS ONE | www.plosone.org

NHANES Data collection and laboratory analysis
Data collected regarding demographic information (age, race,
education, health insurance status, and income to poverty ratio),
current medication use, diagnosis of medical conditions (both
previous and current), and lifestyle behaviors (smoking and alcohol
use) were collected by trained interviewers. Body Mass Index
2
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Table 2. Neutrophil, Lymphocyte, and NLR according to demographic and clinical characteristics (n = 9427).

Neutrophil
Mean (95% CI)

Lymphocyte
Mean (95% CI)

NLR
Mean (95% CI)

Variable

Categories

Race

Hispanic

4.39 (4.31–4.48)

2.26 (2.23–2.29)

2.08 (2.04–2.12)

Non-Hispanic White

4.35 (4.27–4.44)

2.09 (2.06–2.12)

2.24 (2.19–2.28)

Non-Hispanic Black

3.65 (3.56–3.73)

2.24 (2.21–2.28)

1.76 (1.71–1.81)

Other Non-Hispanic

4.18 (4.00–4.37)

2.11 (2.05–2.17)

2.10 (2.01–2.19)

Male

4.26 (4.18–4.33)

2.11 (2.08–2.13)

2.19 (2.14–2.25)

Female

4.28 (4.20–4.36)

2.16 (2.14–2.19)

2.11 (2.07–2.16)

, high school

4.44 (4.32–4.56)

2.22 (2.19–2.26)

2.16 (2.09–2.24)

High school or equiv

4.45 (4.34–4.56)

2.19 (2.15–2.23)

2.20 (2.14–2.26)

. high school

4.13 (4.07–4.20)

2.08 (2.06–2.10)

2.13 (2.08–2.17)

Insured

4.21 (4.14–4.28)

2.10 (2.08–2.12)

2.16 (2.11–2.21)

Uninsured

4.48 (4.37–4.60)

2.26 (2.21–2.30)

2.12 (2.06–2.18)

Yes

4.66 (4.50–4.83)

2.21 (2.15–2.27)

2.34 (2.23–2.45)

No

4.24 (4.17–4.30)

2.13 (2.11–2.15)

2.13 (2.09–2.17)

Borderline

4.27 (3.88–4.67)

2.06 (1.97–2.15)

2.21 (2.01–2.41)

Yes

4.26 (4.19–4.33)

2.14 (2.12–2.16)

2.44 (2.30–2.58)

No

4.45 (4.28–4.61)

2.03 (1.93–2.12)

2.14 (2.10–2.18)

Sex

Education

Health insurance

Diabetes

Heart condition
2

BMI (kg/m )

Ever Smoker

Drinker

,18.5

3.99 (3.64–4.34)

2.10 (1.97–2.23)

2.06 (1.85–2.27)

18.5–24.9

3.97 (3.88–4.07)

2.01 (1.98–2.05)

2.11 (2.06–2.17)

25.0–29.9

4.18 (4.08–4.28)

2.11 (2.08–2.15)

2.13 (2.07–2.20)

$30.0

4.62 (4.54–4.71)#

2.26 (2.23–2.29)#

2.21 (2.15–2.27)*

Yes

4.55 (4.43–4.66)

2.21 (2.19–2.24)

2.22 (2.16–2.28)

No

4.04 (4.00–4.09)

2.07 (2.04–2.10)

2.10 (2.05–2.14)

Yes

4.28 (4.21–4.35)

2.13 (2.10–2.16)

2.16 (2.11–2.20)

No

4.22 (4.11–4.33)

2.12 (2.08–2.16)

2.17 (2.09–2.25)

*P for trend: 0.002;
#
p for trend,0.0001.
doi:10.1371/journal.pone.0112361.t002

(BMI) (kg/m2) was measured during the medical examination.
Laboratory tests were performed on collected blood specimens to
provide information on neutrophil count (1,000 cells/ml) and
lymphocyte count (1,000 cells/ml). NLR was calculated as the ratio
of neutrophil cell count to lymphocyte cell count. The Coulter
method was used to determine neutrophil and lymphocyte counts
(Coulter Gen.S Hematology Analyzer, Beckman Coulter Corp,
Hialeah, Florida).

2011. Stata Statistical Software: Release 12. College Station, TX:
StataCorp LP).

Results
There are 9427 subjects in this study (Table 1), distributed
equally between males and female. The majority of subjects is
white (67%), has completed at least high school or more (55%),
and is covered by some form of insurance (78%). The average age
is 47 years; roughly one third of the subjects is overweight (BMI$
30 km/m2). The rate of comorbidities varies from 4% (heart
condition) to 7% (diabetes). Forty four percent of subjects are
classified as ever smokers, while 76% indentified themselves ad
current drinkers. The average value of neutrophils is 4.2761000
cells/mL, of lymphocytes 2.1461000 cells/mL; the average NLR is
2.15.
NLR was studied in relation to personal and demographic
variables (Table 2). Non-Hispanic Black participants and Hispanic
participants had significantly lower mean NLR values (1.76, 95%
CI 1.71–1.81 and 2.08, 95% CI 2.04–2.12 respectively) when
compared to non-Hispanic Whites (mean NLR = 2.24, 95% CI
2.19–2.28–p,0.0001). Similar results were observed in children
(table S1). Subjects who reported diabetes or a history of heart
condition had higher NLR than subjects who did not, but only
results on hearth condition were statistically significant (p,
0.0001). Ever smokers had significantly higher NLR than non

Data analysis
The distribution of continuous variables was reported as means
6 standard deviation, of categorical variables as frequencies and
percentages. The main outcome of interest, neutrophil, lymphocyte counts and the NLR was reported as mean along with 95%
confidence intervals. To examine the influence of demographic
and clinical characteristics on neutrophil counts, lymphocyte
counts, and NLR, linear regression models for each outcome were
performed, including all the variables found to be statistically
significant at univariate analysis (p,0.05) as well as clinically
meaningful. Multivariate linear regression models were also
stratified by race. All data analyses used the appropriate survey
sample weights to provide nationally representative estimates.
Statistical significance was determined at alpha level of 0.05.
Analyses were performed using Stata/SE version 12 (StataCorp.
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REF
0.10
20.12

,high school

High school or equiv

.high school

Education

0.32
REF
20.16

Yes

No

Borderline

Diabetes

4

doi:10.1371/journal.pone.0112361.t003

Yes vs No

Yes vs No
20.02

0.46

0.71

$30.0

Ever Smoker

(0.57–0.85)

0.24

25.0–29.9

Drinker

(0.09–0.38)

REF

18.5–24.9

(20.14–0.10)

(0.33–0.60)

(20.37–0.45)

0.04

,18.5

(2.13–.24)

BMI (kg/m2)

.06

Yes vs No

(20.56–0.23)

(0.15–0.48)

(0.02–0.38)

(20.08–20.02)

(20.25–0.004)

(20.02–0.21)

(20.009–20.004)

(0.06–0.26)

(20.2120.24)

(21.03 220.81)

(20.27220.01)

95% CI

Heart condition

0.20

Uninsured vs Insured

Health insurance

20.05

Continuous

Income/poverty ratio

20.007

Continuous

Age (years)

0.16

Female vs Male

Sex

20.92
20.02

Non-Hispanic Black

REF

Other Non-Hispanic

20.14

Hispanic

Non-Hispanic White

Race

Coeff

Categories

Variable

Neutrophil

0.73

,0.0001

,0.0001

0.003

0.85

0.55

0.40

,0.0001

0.03

0.003

0.06

0.09

,0.0001

0.002

0.89

,0.0001

0.03

p-value

0.005

0.15

0.27

0.12

REF

0.04

20.09

20.12

REF

0.08

0.05

20.01

20.06

20.013

REF

20.006

0.10

0.05

0.10

REF

0.09

Coeff

Lymphocyte

0.002

(20.04–0.05)

(0.12–0.19)

(0.23–0.31)

(0.07–0.16)

(20.10–0.17)

(20.21–0.03)

(20.24–20.11)

(0.02–0.14)

(20.07–0.10)

0.81

,0.0001

,0.0001

,0.0001

0.59

0.13

0.03

0.009

0.09

0.14

(20.10–20.03)
(20.02–0.003)

0.55

,0.0001

,0.0001

0.24

,0.0001

,0.0001

p-value

(20.06–0.31)

(20.007–20.005)

(0.07–0.14)

(20.04–0.13)

(0.06–0.15)

(0.05–0.13)

95% CI

20.03

0.09

0.08

20.005

REF

0.008

0.17

20.006

REF

0.11

0.02

20.03

20.01

0.05

REF

0.004

20.06

20.07

20.55

REF

20.18

Coeff

NLR

(20.13–0.07)

(0.02–0.16)

(0.001–0.15)

(20.10–0.09)

(20.22–0.24)

(0.05–0.30)

(20.22–0.21)

(20.004–0.23)

(20.06–0.10)

(20.05–0.007)

(20.09–0.06)

(20.04–0.14)

(0.002–0.006)

(20.13–0.006)

(20.1920.05)

(20.61220.49)

(20.26220.11)

95% CI

0.55

0.015

0.046

0.91

0.94

0.008

0.95

0.06

0.61

0.01

0.72

0.29

,0.0001

0.07

0.24

,0.0001

,0.0001

p-value

Table 3. Adjusted Linear Regression Estimates of the association between demographic and clinical characteristics and Neutrophil and Lymphocyte Values (n = 7736).
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Table 4. Linear Regression Estimates (b coefficients and 95% CI) of the association between clinical and demographic
characteristics and NLR according to racial subgroups.

Variable

Categories

Blacks
(n = 1440)

Sex

Female vs Male

20.09 (20.19–0.007)

20.10 (20.19– 20.02)‘

Age (years)

Continuous

0.001 (20.001–0.005)

0.005 (0.002–0.007)

Education

,high school

REF

REF

REF

High school

0.08 (20.05–0.21)

2 0.001 (20.13–0.13)

0.10 (20.03–0.23)

Income/poverty ratio

Whites
(n = 3684)

Hispanics
(n = 2255)
0.04 (20.05–0.13)

#

.high school

0.06 (2.08–0.19)

20.06 (20.18–0.05)

Continuous

20.02 (20.05–0.02)

20.03 (20.06– 20.008)

0.002 (20.0001–0.006)

0.02 (20.04–0.09)
‘

20.03 (20.06–0.003)

Health insurance

Uninsured vs Insured

20.05 (20.16–0.05)

0.02 (20.10–0.13)

20.02 (20.13–0.08)

Diabetes

Yes

0.16 (20.04–0.37)

0.15 (20.05–0.34)

20.02 (20.13–0.09)

No

REF

REF

REF

Borderline

0.33 (20.01–0.66)

20.05 (20.33–0.24)

20.10 (20.28–0.09)

Yes vs no

0.11 (20.11–0.33)

0.15 (20.01–0.31)

0.21 (0.002–0.42)*

Heart condition
BMI (kg/m2)

,18.5

0.12 (20.50–0.73)

20.02 (20.31–0.28)

20.11 (20.92–0.69)

18.5–24.9

REF

REF

REF

25.0–29.9

20.001 (20.19–0.19)

20.01 (20.13–0.11)

20.01 (2.12–0.11)

$30.0

0.15 (0.0005–0.29)*

0.05 (20.06–0.15)

0.07 (2.05–0.20)

Ever Smoker

Yes vs no

0.02 (20.08–0.12)

0.09 (0.002–0.18)*

0.01 (20.07–0.10)

Drinker

Yes vs no

0.06 (20.03–0.15)

20.06 (20.20–0.08)

0.06 (20.04–0.16)

*p = 0.04;
#
p,0.0001;
‘p = 0.01.
doi:10.1371/journal.pone.0112361.t004

populations were mostly small in size, without consideration of
racial differences and racial composition.
Because of the lower NLR observed in black in comparison to
white subjects, it is possible that commonly reported high
prognostic NLR cut-off points be hardly reached by non-white
populations, or be a much worst prognostic indicator than in white
patients. All these speculations need to be tested in multi ethnic
populations affected by chronic diseases such as cancer and
cardiovascular disease.
Another result of this analysis is that NLR is associated with
several self-reported chronic conditions, such as diabetes and heart
disease, with being a smoker, with high BMI, and with increasing
age, all conditions that are known to increase the body
inflammatory milieu [26]. In addition this study shows that an
index of socioeconomic status, the income to poverty ratio, is
inversely associated with NLR. A low socio economic status may
be a proxy for poor dietary habits, low in nutrients and antioxidants, or lack of physical exercise, or occupational exposures to
chemicals and carcinogens. We are not able to test these
hypotheses given the retrospective nature of the NHANES data
base, and the limited information available from the questionnaire.
This analysis also shows that the association between personal
and behavioral factors and NLR differs with race. For example,
among black patients only BMI was significantly associated with
elevated NLR, while among white patients several expected
factors, such as age and smoking habits were associated with
higher NLR. These differences may be due to chance, or to a
different host response to pro-inflammatory factors, a hypothesis
that needs to be tested in ad hoc studies.
Despite the fact that this analysis relies on a large sample of the
US population, a larger sample size collected over longer periods
of time would help better defining NLR normal ranges. In

smokers (p = 0.001). There were no significant differences in NLR
with sex, education, insurance status, or drinking habits. There
was a significant trend of increasing NLR with increasing BMI (p
for trend: 0.002). The associations persisted after adjustment for
confounding factors (table 3). In addition NLR was significantly
associated with increasing age and inversely associated with
income poverty ratio.
When the analysis was repeated according to race (Table 4),
among black subjects a high NLR was significantly associated only
with increasing BMI (b coefficient = 0.15, 95% CI 0.0005–0.29).
Among non-Hispanic Whites, older age (p,0.0001) and being a
smoker (p = 0.04) were positively associated with increasing NLR
values, while income to poverty ratio was negatively associated
with NLR (p = 0.01); women had significantly lower NLR values
compared to men (b coefficient = 20.10, 95% CI 20.19– 20.02;
p = 0.01). Among Hispanics, only having a heart condition was
significantly associated with an increased NLR (b coefficient = 0.21, 95% CI 0.002–0.42; p = 0.04).

Discussion
The present analysis of a large US data set including over 9000
subjects reports the average value for NLR in the general
population, and indicates that such normal value significantly
varies with race; NLR is particularly low in Non-Hispanic Black
subjects, from 2.24 observed in Whites to 1.76 in Blacks. This
finding has important clinical implications. Several publications
demonstrated that an elevated NLR is a predictor of poor outcome
in cancer [7] and cardiovascular disease [5]; these studies however
used arbitrary NLR cut off points for risk stratification, which were
based on the average NLR values of each study population. Such
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addition, the NLR was an occasional, single measure, and as such
does not reflect individual variability. Another limitation is that all
the exposure variables, including race were self-reported, thus
their accuracy could not be objectively verified. However, it is
unlikely that the answers to the questionnaire could differ
according to the NLR, since the participants were not aware of
the results of the test.
This study is providing preliminary data on racial disparities in
a marker of inflammation (NLR) that has been associated with
several chronic diseases outcome, suggesting that different cut-off
points should be set according to race. It also shows how NLR is
associated with personal and behavioral factors, some of which are
modifiable such as smoking and BMI. It suggests that together
with public health interventions of the factors amenable of being
modified, chemopreventive trials should be considered in an
attempt to modify NLR in ageing people, smokers and populations
at risk for chronic diseases such as cardiovascular disease and
cancer.

with average NLR of 1.76, 2.08 and 2.24, respectively. The results
corroborate prior studies on inflammation in reporting the
association between elevated NLR and risk factors such as
smoking, obesity, and diabetes. Moreover, differences in the
association between some of these risk factors and elevated NLR
across different races were observed. This may illustrate racial
differences in inflammatory response to different risk factors, some
of which are modifiable.
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neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment
elevation myocardial infarction. Am J Cardiol 101(6): 747–52.

PLOS ONE | www.plosone.org

6

November 2014 | Volume 9 | Issue 11 | e112361

